- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Sclerosis
Total 10006 results
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Opexa Therapeutics, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
NeurognosticsTerminatedRelapsing-Remitting Multiple SclerosisUnited States
-
Instituto Universitario de Oftalmobiología Aplicada...Hospital del Río Hortega; Fundación Eugenio Rodríguez PascualEnrolling by invitationProgressive Multiple Sclerosis | Multiple Sclerosis | Clinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisSpain
-
Atara BiotherapeuticsTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States, Australia, Canada
-
University Hospital, CaenActive, not recruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisFrance
-
Rennes University HospitalRecruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisFrance
-
Judit PichRecruitingRelapsing-Remitting Multiple SclerosisSpain
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisSpain, Czechia, Bulgaria, Serbia, Russian Federation, Ukraine, Poland, Slovakia
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
Kessler FoundationActive, not recruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisUnited States
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, GermanyCompletedRelapsing-Remitting Multiple SclerosisUnited Kingdom
-
Anokion SAActive, not recruitingRelapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)United States
-
Ohio State UniversityNational Multiple Sclerosis SocietyCompleted
-
Karolinska InstitutetPatient-Centered Outcomes Research Institute; Kaiser Foundation Research InstituteActive, not recruitingRelapsing-remitting Multiple SclerosisSweden
-
BiocadCompletedRelapsing-remitting Multiple Sclerosis
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
Charite University, Berlin, GermanyDr. Carmen Infante-DuarteTerminatedRelapsing-Remitting Multiple SclerosisGermany
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Czechia, Hungary, Austria, Belgium, Canada, Portugal, Slovakia, Slovenia
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisKorea, Republic of, Taiwan, Czechia, Japan, Poland
-
Eli Lilly and CompanyCompletedRelapsing-Remitting Multiple SclerosisHungary, United States, France, Ukraine, Poland, Germany, Israel, Russian Federation, Czechia, Serbia, Romania, Slovakia, Bulgaria
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
Nantes University HospitalCompletedRelapsing-remitting Multiple SclerosisFrance
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisGermany
-
Universita di VeronaCompletedRelapsing-Remitting Multiple SclerosisItaly
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Claudio GobbiOspedale Civico, LuganoCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Claudio GobbiBayerTerminatedRelapsing-remitting Multiple SclerosisSwitzerland
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceCompletedMultiple Sclerosis, Relapsing, Remitting
-
Coordinación de Investigación en Salud, MexicoCompleted
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Universita di VeronaCompletedRelapsing-remitting Multiple SclerosisItaly
-
University Hospital Inselspital, BernePharmaPart; Viollier AG, Basel, SwitzerlandCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
Cantonal Hospital of St. GallenUnknownRelapsing-Remitting Multiple SclerosisSwitzerland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
NeurognosticsCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
University of Alabama at BirminghamWashington University School of Medicine; United States Department of DefenseRecruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisCanada
-
Universitätsklinikum Hamburg-EppendorfNeovii Biotech; Clinical Trial Center North (CTC North GmbH & Co. KG)TerminatedRelapsing-Remitting Multiple SclerosisGermany
-
Opexa Therapeutics, Inc.CompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Innobioscience SpAPontificia Universidad Catolica de Chile; University of Chile; Universidad Austral...UnknownMultiple Sclerosis, Secondary Progressive | Primary Progressive Multiple SclerosisChile
-
BayerCompletedRelapsing-remitting Multiple SclerosisFrance